packageOcrelizumab
ocrelizumab
Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).
Information
Ocrelizumab is an anti-CD20 monoclonal antibody used to treat multiple sclerosis. It is authorised in the European Union and is an approved medicine, though it has also been investigated for other conditions such as B cell leukemia.
Summary written by glm-5.3-flash from Wikidata Q2013780 and the WHO ATC classification and the EMA medicines list; not checked by a person.
| name: | ocrelizumab |
| ATC codes: | L04AG08 |
| DrugBank: | DB11988 |
| Wikidata: | Q2013780 |
| molar mass: | 145000 g/mol (Drugs.Common 25.09, not verified) |
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| String | name (from PartialSubstance) | "" | INN / common name |
| String[:] | atcCodes (from PartialSubstance) | fill("", 0) | all WHO ATC codes of the drug |
| String | drugbankId (from PartialSubstance) | "" | e.g. DB00758 |
| String | pubchemCid (from PartialSubstance) | "" | PubChem compound id |
| String | chebiId (from PartialSubstance) | "" | ChEBI id (number) |
| String | wikidataId (from PartialSubstance) | "" | e.g. Q410238 |
| String | formula (from PartialSubstance) | "" | molecular formula |
| Modelica.Units.SI.MolarMass | M (from PartialSubstance) | 0 | molar mass; 0 = unknown |
| Real | logP (from PartialSubstance) | Modelica.Constants.inf | octanol-water partition coefficient (log10); inf = unknown |